CVM

Conviction 54HealthcareScan · Mon, Aug 10, 2026

CVM$1.49-13.66%

ResistanceSupportVol 14Insider buy

Vol MA14 260.54K

May 11May 28Jun 16Jul 6Jul 23Aug 10

CEL SCI CORPBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.cel-sci.com ↗

Price1.49

Change-13.66%

Gap-1.74%

Rel volume1.78×

Avg volume344.33K

Avg $ vol439.01K

SMA 201.28

SMA 501.24

SMA 2003.89

Price vs 50+19.73%

Price vs 200-61.85%

MA stackmixed

50/200 cross—

Supertrendup · 1.28

RSI (14)58

MACD hist0.05

MACD cross—

Stoch %K / %D59 / 85

ADX (14)31

+DI / −DI35 / 15

RSI divergence—

MACD divergence—

ATR %+9.13%

ADR %9.75%

52w high13.04

52w low0.9744

From 52w high-88.61%

Above 52w low+52.40%

New 52w highNo

SqueezeOff

Bollinger width51.75%

%B0.81

Donchian pos63.12%

Donchian high1.73

Donchian low1.07

AVWAP (52w high)3.24

vs AVWAP high-54.22%

AVWAP (52w low)1.26

vs AVWAP low+17.99%

OBV trendUp

Chaikin MF (20)-0.02

Today vs 20d1.78×

Avg vol (14d)260.54K

Avg vol (20d)344.33K

Avg $ vol (20d)439.01K

Market cap12.61M

RS 3m (vs SPY)+1.80%

RS 6m (vs SPY)-79.01%

RS line new highNo

Trend template3/8

Technical rank33.2

1 week+18.80%

1 month+7.61%

3 months-12.65%

6 months-70.30%

1 year-81.96%

YTD-71.17%

P/E-0.50

P/B1.83

P/S47.77

P/FCF-0.74

EPS-6.27

Div yield—

ROE-369.63%

ROA-143.51%

Debt/Eq—

Current0.60

EV/EBITDA-0.33

Gross margin—

Net margin—

Rev growth65.45%

EPS growth5.61%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value7.48M

Revenue77.4K

Net income-5.47M

Gross profit—

Free cash flow-17.16M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNYSE

Shares out8.49M

Employees44

ListedThu, Dec 8, 1983

Free float8.12M

Float %96.0%

Short interest718.01K

Days to cover1.8d

Short volume37.4%

Squeeze score38 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction54 / 100

Pattern quality—

Tech rank33.2 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.44

Support0.9774

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CVM

All disclosures →

No recent disclosed trades by Congress in CVM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CVM · 2 buys

Insider	Side	Shares	Value	Traded	Filed
KERSTEN GEERT R Chief Executive Officer · Common Stock · 2026-05-14	Buy	300K	$360K	2026-05-14	2026-05-18
KERSTEN GEERT R Chief Executive Officer · Common Stock · 2026-05-14	Other	—	—	2026-05-14	2026-05-18
KERSTEN GEERT R Chief Executive Officer · Common Stock · 2026-05-13	Buy	100K	$119K	2026-05-13	2026-05-14

SEC filings

EDGAR filings in CVM · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.